Hello, rapid* relief
As early as Day 4 with EYSUVIS® (loteprednol etabonate ophthalmic suspension) 0.25%
If you’re looking for relief, it’s time to learn about EYSUVIS® and how it may be able to help you during dry eye flare-ups
Treats signs + symptoms
Proven to relieve eye redness and discomfort caused by dry eye disease
Goes to the site of inflammation
Delivers medication to the site of the inflammation that causes symptom flare‑ups
Works fast*
Fast dry eye discomfort relief as early as 4 days after starting treatment
*In a clinical trial program with 2871 patients with dry eye, patients using EYSUVIS® showed significant reduction in the symptoms of dry eye (ocular discomfort) as early as Day 4 after starting treatment (compared to placebo). Symptoms continued to improve up to the end of the treatment period (Day 15). Patients taking EYSUVIS® also showed significant reduction in signs of dry eye (eye redness) at Day 15 compared to placebo.
Make an appointment with your eye doctor today
When dry eye symptoms flare up, it’s time to speak up. Even if you aren’t experiencing a flare‑up right now, if you’ve had flares before, there’s a good chance you’ll face those symptoms again. So don’t wait—make an appointment to see if EYSUVIS® could be right for you.
Frequently Asked Questions
EYSUVIS® (loteprednol etabonate ophthalmic suspension) 0.25% is a prescription medicine approved for short-term treatment (up to 2 weeks) of signs and symptoms of dry eye disease.
EYSUVIS® works by reducing inflammation in your eyes caused by dry eye disease.
Just apply 1 to 2 drops into each affected eye 4 times a day for up to 2 weeks as directed by your doctor.
The cost of EYSUVIS® may vary depending on the pharmacy you visit and your insurance plan.
However, you may be able to save money by using a coupon or a co-pay card from Alcon. For eligible patients with commercial insurance, the co-pay card may reduce the cost of EYSUVIS®.
EYSUVIS® should not be used if you have a viral infection in your eye. Talk to your doctor before using EYSUVIS® if you think you may have a viral, bacterial, or fungal eye infection.
The most common side effect following the use of EYSUVIS® for 2 weeks was instillation eye pain, which was reported in 5% of patients.
Start saving on your EYSUVIS® prescription
~80% of patients who suffer from dry eye symptoms experience flares.† Make sure you’re ready for a flare-up.
2018 Lieberman Dry Eye Patient Survey (N=297).
EYSUVIS® is a corticosteroid indicated for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease.
IMPORTANT SAFETY INFORMATION
EYSUVIS® should not be used if you have a viral infection in your eye. Talk to your doctor before using EYSUVIS® if you think you may have a viral, bacterial, or fungal eye infection.
Your doctor should examine your eyes before prescribing EYSUVIS®, to check for increased eye pressure or damage to the surface of the eye. Consult your doctor if pain, redness, itching, or inflammation develops or gets worse.
Wash your hands well before each use. Do not allow the dropper tip to touch any surface, as this may contaminate the suspension. Shake the bottle for two to three seconds before using. If a dose is missed, take the missed dose when remembered.
Remove contact lenses before using EYSUVIS®; they may be reinserted 15 minutes later.
The most common adverse drug reaction following the use of EYSUVIS® for two weeks was instillation site pain, which was reported in 5% of patients.
View full Prescribing Information for EYSUVIS®.